TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
6.17
-0.43 (-6.51%)
At close: May 18, 2026, 4:00 PM EDT
6.40
+0.23 (3.73%)
After-hours: May 18, 2026, 5:41 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $5.86 million as of May 18, 2026. Its market cap has decreased by -38.22% in one year.
Market Cap
5.86M
Enterprise Value
-6.97M
1-Year Change
-38.22%
Ranking
Category
Stock Price
$6.17
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $5.86M, a decrease of -87.75%. That is a compound annual growth rate of -35.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 5.86M | -6.38% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | 47.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Purple Biotech | 6.40M |
| GeoVax Labs | 6.39M |
| Silo Pharma | 6.31M |
| CollPlant Biotechnologies | 6.27M |
| XTL Biopharmaceuticals | 6.19M |
| Moolec Science | 6.04M |
| FibroBiologics | 5.89M |
| Alaunos Therapeutics | 5.85M |